These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
915 related items for PubMed ID: 19644853
1. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment. Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Frampton C, James J, Barclay ML. Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853 [Abstract] [Full Text] [Related]
2. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy. Stamp LK, O'Donnell JL, Chapman PT, Zhang M, James J, Frampton C, Barclay ML. Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Dalrymple JM, Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Barclay ML. Arthritis Rheum; 2008 Nov; 58(11):3299-308. PubMed ID: 18975321 [Abstract] [Full Text] [Related]
4. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations. Becker ML, van Haandel L, Gaedigk R, Lasky A, Hoeltzel M, Stobaugh J, Leeder JS. Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581 [Abstract] [Full Text] [Related]
5. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Dervieux T, Furst D, Lein DO, Capps R, Smith K, Walsh M, Kremer J. Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444 [Abstract] [Full Text] [Related]
6. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study. Dervieux T, Furst D, Lein DO, Capps R, Smith K, Caldwell J, Kremer J. Ann Rheum Dis; 2005 Aug; 64(8):1180-5. PubMed ID: 15677700 [Abstract] [Full Text] [Related]
7. Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis. Stamp LK, Barclay ML, O'Donnell JL, Zhang M, Drake J, Frampton C, Chapman PT. J Rheumatol; 2011 Dec; 38(12):2540-7. PubMed ID: 21965639 [Abstract] [Full Text] [Related]
10. Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis. de Rotte MC, de Jong PH, den Boer E, Pluijm SM, Özcan B, Weel AE, Lindemans J, Hazes JM, de Jonge R. Arthritis Rheumatol; 2014 Aug; 66(8):2026-36. PubMed ID: 24692301 [Abstract] [Full Text] [Related]
11. Factors influencing length of time taking methotrexate in rheumatoid arthritis. Ortendahl M, Schettler JD, Fries JF. J Rheumatol; 2000 May; 27(5):1139-47. PubMed ID: 10813279 [Abstract] [Full Text] [Related]
13. Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis. Dervieux T, Zablocki R, Kremer J. Rheumatology (Oxford); 2010 Dec; 49(12):2337-45. PubMed ID: 20713496 [Abstract] [Full Text] [Related]
14. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis. Dolezalová P, Krijt J, Chládek J, Nemcová D, Hoza J. Rheumatology (Oxford); 2005 Jan; 44(1):74-9. PubMed ID: 15454631 [Abstract] [Full Text] [Related]
15. Patients with rheumatoid arthritis treated with methotrexate (MTX): concentrations of steady-state erythrocyte MTX correlate to plasma concentrations and clinical efficacy. Hornung N, Ellingsen T, Attermann J, Stengaard-Pedersen K, Poulsen JH. J Rheumatol; 2008 Sep; 35(9):1709-15. PubMed ID: 18634162 [Abstract] [Full Text] [Related]
16. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis. Fathi NH, Mitros F, Hoffman J, Straniero N, Labreque D, Koehnke R, Furst DE. J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317 [Abstract] [Full Text] [Related]
17. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis. den Boer E, de Rotte MC, Pluijm SM, Heil SG, Hazes JM, de Jonge R. J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283 [Abstract] [Full Text] [Related]
18. Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritis. Pan S, Stamp LK, Duffull SB, Barclay ML, Dalrymple JM, Drake J, Zhang M, Korell J. Clin Pharmacokinet; 2014 Dec; 53(12):1161-70. PubMed ID: 25204405 [Abstract] [Full Text] [Related]
19. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis. Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M. J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431 [Abstract] [Full Text] [Related]
20. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients. Sokka T, Pincus T. J Rheumatol; 2002 Dec; 29(12):2521-4. PubMed ID: 12465145 [Abstract] [Full Text] [Related] Page: [Next] [New Search]